All Regulatory Rapporteur articles in November 2024
View all stories from this issue.
-
-
Industry newsGreater post-market surveillance for medical devices
New draft legislation was laid before the UK Parliament on 21 October 2024 which would require greater post-market surveillance (PMS) for medical devices on the market in Great Britain.
-
Industry newsNew cancer drug approved by MHRA
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new drug for non-small cell lung cancer (NSCLC) via a national procedure.
-
Industry newsNew guidance for wholesalers and manufacturers following Windsor Framework
The Medicines & Healthcare products Regulatory Agency (MHRA) recently published new regulatory guidance for human medicine wholesalers and manufacturers operating within the United Kingdom (UK).
-
-
-
-
-
-
-
-
-
-
-
-
-
JournalPS1: Resolving specific development hurdles via scientific advice
Regulatory Rapporteur November 2024 | Volume 21 | No.10 Leaders: Sandra Lourenço, Director of Regulatory Affairs, Arriello, Ireland Andrea Laslop, Head of Scientific Office, Austrian Agency for Health and Food Safety, Austria Speakers: Peggy Sarah, the ...
-
-
-
